Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q1 2025 · 10-Q
Revenue$604.70M$604.70M+6.7% vs Q1 2024 Net Income-$15.48M-$15.48MN/M vs Q1 2024 EPS Diluted-$0.63-$0.63N/M vs Q1 2024 Gross Profit$210,109,000+13.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flow$51,327,000+12.1% Free Cash Flowderived$36,706,000+22.9% Margins · derivedGross margin34.7%+2.1 pt vs Q1 2024
Operating margin2.1%+4.0 pt vs Q1 2024
Net margin-2.6%+4.4 pt vs Q1 2024
ended Mar 31, 2025 · filed May 8, 2025 · 38 d after period end